Cite
HARVARD Citation
Ferdowsi, N. et al. (2019). Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis. Annals of the rheumatic diseases. 78 (6), pp. 807-. [Online].